![](https://unicorn-nest.com/wp-content/uploads/2021/11/MBLVC.png?x55332)
MBL Venture Capital is the famous VC, which was founded in 2000. The company was established in Asia in Japan. The main department of described VC is located in the Nagoya.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the MBL Venture Capital, startups are often financed by Morgenthaler Ventures, Advanced Technology Ventures. The meaningful sponsors for the fund in investment in the same round are Shin Nippon Biomedical Laboratories (SNBL), Seraph Group, SR One. In the next rounds fund is usually obtained by SR One, Mitsubishi UFJ Capital, Tohoku University Venture Partners.
Among the various public portfolio startups of the fund, we may underline Second Genome, TMS Co., Ltd., Sentien Biotechnologies We can highlight the next thriving fund investment areas, such as Pharmaceutical, Life Science. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2016.
Related Funds
Funds with similar focus
Fund Name | Location |
Accelerator Technology Holdings | Amman, Amman, Jordan |
Alphachain | Puerto Rico, San Juan, United States |
Aston Hill Financial | Canada, Ontario, Toronto |
Beni VC | Florida, Miami, United States |
BXR Partners LLP | - |
China Literature | Beijing, Beijing, China |
China Urban Realty Association | Beijing, Beijing, China |
Dragon Ventures | China, Hong Kong, Hong Kong Island |
Edu-Capital | Beijing, Beijing, China |
Globivest | Beirut, Beyrouth, Lebanon |
IN Venture | Israel, Tel Aviv, Tel Aviv |
Lantianshi Chuangtou | Beijing, China, Haidian |
METABRIDGE | British Columbia, Canada, Vancouver |
Naranya | Colima, Mexico, Nuevo |
Pinnacle Systems | California, Mountain View, United States |
Royal Enfield | Gurgaon, Haryana, India |
Sunrise Capital Partners | New York, New York, United States |
Xing Fu Cheng | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Himuka AM Pharma | $3M | 30 Mar 2018 | Chiyoda, Japan | ||
Sentien Biotechnologies | $12M | 04 Apr 2017 | Massachusetts, United States | ||
Second Genome | $51M | 13 Apr 2016 | San Francisco, California, United States | ||
Sentieon | $3M | 04 Apr 2014 | Mountain View, California, United States | ||
TMS | $330K | 01 Nov 2011 | Fuchu |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Himuka AM Pharma | $3M | 30 Mar 2018 | Chiyoda, Japan | ||
Sentien Biotechnologies | $12M | 04 Apr 2017 | Massachusetts, United States | ||
Second Genome | $51M | 13 Apr 2016 | San Francisco, California, United States | ||
Sentieon | $3M | 04 Apr 2014 | Mountain View, California, United States | ||
TMS | $330K | 01 Nov 2011 | Fuchu |